School of Medicine


Showing 1-100 of 201 Results

  • Bruce T. Adornato

    Bruce T. Adornato

    Adjunct Clinical Professor, Adult Neurology

    BioDr. Adornato joined the Department of Neurology as Voluntary Clinical Faculty in 1978, (subsequently Adjunct Clinical Faculty) and has served as Director of the Neuromuscular Laboratory from 1978 until 1983, performing and interpreting nerve and muscle biopsies as well as serving as attending physician directing residents and medical students in the diagnosis and care of his private patients admitted to Stanford Hospital. Since 1986, he has been attending physician at the Palo Alto VA Hospital, directing Stanford Neurology residents and medical students in the care of veterans. He has published 69 peer reviewed papers and a number of book chapters in the field of neurology. He is currently the medical officer of a silicon valley startup exploring mobility devices for the neurologically impaired.

  • Gregory W. Albers, MD

    Gregory W. Albers, MD

    Coyote Foundation Professor and Professor, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsOur group’'s research focus is the acute treatment and prevention of cerebrovascular disorders. Our primary interest is the use of advanced imaging techniques to expand the treatment window for ischemic stroke. We are also conducting clinical studies of both neuroprotective and thrombolytic strategies for the treatment of acute stroke and investigating new antithrombotic strategies for stroke prevention.

  • Katrin Andreasson

    Katrin Andreasson

    Edward F. and Irene Thiele Pimley Professor of Neurology and Neurological Sciences

    Current Research and Scholarly InterestsOur research focuses on understanding how immune responses initiate and accelerate synaptic and neuronal injury in age-related neurodegeneration, including models of Alzheimer's disease and Parkinson's disease. We also focus on the role of immune responses in aggravating brain injury in models of stroke. Our goal is the identification of critical immune pathways that function in neurologic disorders and that can be targeted to elicit disease modifying effects.

  • Meredith Barad, MD

    Meredith Barad, MD

    Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
    Clinical Associate Professor (By courtesy), Adult Neurology

    Current Research and Scholarly InterestsMy current research interests involve novel treatment paradigms for challenging pain problems such as orofacial pain, trigeminal neuralgia and low pressure headaches. I am also interested in migraine and trigeminal autonomic cephalgias and their intersection with chronic pain.

  • Richard Baron, MD

    Richard Baron, MD

    Clinical Assistant Professor, Adult Neurology
    Clinical Assistant Professor (By courtesy), Otolaryngology (Head and Neck Surgery)

    BioDr. Baron is a board-certified, fellowship-trained neurologist in the Stanford Health Care Headache Clinic and the Vestibular Balance Disorders Program. He is also clinical assistant professor in the Department of Neurology & Neurological Sciences and, by courtesy, in the Department of Otolaryngology – Head & Neck Surgery at Stanford University School of Medicine. He received fellowship training in both headache medicine and otoneurology (dizziness and vestibular disorders) at Stanford University School of Medicine.

    He specializes in diagnosing, managing, and treating the many causes of headache, facial pain, and dizziness. To provide the highest level of care, he takes a detailed history, performs a specialized physical exam, and collaborates with colleagues across the Stanford Health Care system. Dr. Baron develops a comprehensive care plan customized for each patient. He specializes in non-medication options, nerve blocks and other advanced treatments, Botox® injections, and the latest headache medications and devices.

    Dr. Baron has a particular interest in the management of idiopathic intracranial hypertension (IIH), which results from pressure around the brain and causes headaches and problems with vision. He has established a multidisciplinary group of Stanford Health Care doctors to improve and coordinate care for people with IIH. The group includes doctors from several departments, including neuro-ophthalmology, neurosurgery, interventional radiology, and bariatric surgery and medical weight loss. They work together to determine the most effective medical and procedural treatments.

    Dr. Baron also has a strong interest in the evaluation of acute vestibular syndromes and the management of dizziness in the emergency room. He has published in Journal of the Neurological Sciences, Otolaryngologic Clinics of North America, and Translational Behavioral Medicine. He has also written several chapters for the Stanford Neurology Resident Handbook. He has presented his research at conferences throughout the United States, and he is heavily involved with quality improvement projects and educating resident physicians.

    Dr. Baron is a member of the American Headache Society, American Academy of Neurology, Catholic Medical Association, and Alpha Omega Alpha Honor Medical Society.

  • Fiona Baumer

    Fiona Baumer

    Assistant Professor of Neurology and Neurological Sciences (Pediatric Neurology) and of Pediatrics

    Current Research and Scholarly InterestsCauses of Disturbed Cognition in Pediatric Epilepsy

  • Ritwik Bhatia, MD

    Ritwik Bhatia, MD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Bhatia is a board-certified, fellowship-trained neurologist with Stanford Health Care and a clinical assistant professor in the Department of Neurology and Neurological Sciences, Division of Neurocritical Care at Stanford University School of Medicine.

    Dr. Bhatia provides critical care to patients following acute neurological injuries, such as stroke, traumatic brain injury, and other disorders affecting the brain, spinal cord, and nervous system. He focuses on patient outcomes and improving the quality and delivery of neurocritical care through education.

    Dr. Bhatia’s research interests include understanding long-term outcomes for a range of critical care survivors and the impact of neurocritical care interventions, both routine and new, on these outcomes. He is actively working towards developing a post-neurointensive care recovery clinic at Stanford Health Care.

    Dr. Bhatia has published in several peer-reviewed journals, including Neurology, Journal of Neurosurgery, and Stroke. He has presented to his peers at numerous national and regional meetings, including the American Academy of Neurology, Society of Vascular and Interventional Neurology, and American Epilepsy Society.

    Dr. Bhatia is a member of the Neurocritical Care Society and American Academy of Neurology.

  • Helen Bronte-Stewart, MD, MS

    Helen Bronte-Stewart, MD, MS

    John E. Cahill Family Professor, Professor of Neurology and Neurological Sciences (Adult Neurology) and, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsMy research focus is human motor control and brain pathophysiology in movement disorders. Our overall goal is to understand the role of the basal ganglia electrical activity in the pathogenesis of movement disorders. We have developed novel computerized technology to measure fine, limb and postural movement. With these we are measuring local field potentials in basal ganglia nuclei in patients with Parkinson's disease and dystonian and correlating brain signalling with motor behavior.

  • Axel Brunger

    Axel Brunger

    Professor of Molecular and Cellular Physiology, of Neurology and Neurological Sciences, of Photon Science and, by courtesy, of Structural Biology

    Current Research and Scholarly InterestsOne of my primary goals is to elucidate the molecular mechanisms of synaptic neurotransmitter release by conducting imaging and single-molecule/particle reconstitution experiments, in conjunction with near-atomic resolution structural studies of the synaptic vesicle fusion machinery.

  • Paul Buckmaster, DVM, PhD

    Paul Buckmaster, DVM, PhD

    Professor of Comparative Medicine and of Neurology and Neurological Sciences

    Current Research and Scholarly InterestsMechanisms of epilepsy, especially temporal lobe epilepsy.

  • Marion S. Buckwalter, MD, PhD

    Marion S. Buckwalter, MD, PhD

    Professor of Neurology and Neurological Sciences (Adult Neurology) and of Neurosurgery
    On Partial Leave from 11/01/2024 To 10/31/2025

    Current Research and Scholarly InterestsThe goal of the Buckwalter Lab is to improve how people recover after a stroke. We use basic and clinical research to understand the cells, proteins, and genes that lead to successful recovery of function, and also how complications develop that impact quality of life after stroke. Ongoing projects are focused on understanding how inflammatory responses are regulated after a stroke and how they affect short-term brain injury and long term outcomes like dementia and depression.

  • Felix Chang, MD

    Felix Chang, MD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Felix Chang's clinical practice mainly involves intraoperative neurophysiologic monitoring (IONM) and the treatment of neurological disorders with botulinum toxin. He earned his medical degree at the University of Texas Southwestern Medical Center. He completed his neurology residency at the Harvard Neurology Program at the Beth Israel Deaconess Medical Center in Boston. He then went on to complete a fellowship in clinical neurophysiology with a focus in intraoperative neurophysiologic monitoring at Stanford.

  • Steven D. Chang, MD

    Steven D. Chang, MD

    Robert C. and Jeannette Powell Neurosciences Professor and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Neurology and Neurological Sciences

    Current Research and Scholarly InterestsClinical research includes studies in the treatment of cerebrovascular disorders, such as aneurysms and AVMs, as well as the use of radiosurgery to treat tumors and vascular malformations of the brain and spine.

    Dr. Chang is C0-Director of the Cyberknife Radiosurgery Program.

    Dr. Chang is also the head of the The Stanford Neuromolecular Innovation Program with the goal of developing new technologies to improve the diagnosis and treatment of patients affected by neurological conditions.

  • Gaurav Mohit Chattree

    Gaurav Mohit Chattree

    Instructor, Adult Neurology

    BioDr. Chattree is a board-certified neurologist with the Stanford Movement Disorders Center and an Instructor in the Department of Neurology and Neurological Sciences. He provides comprehensive care for patients with movement disorders, which includes deep brain stimulation evaluation/programming and botulinum toxin injections. In addition to his clinical practice, Dr. Chattree conducts research in the lab of Dr. Mark Schnitzer at Stanford, where he uses optical and genetic techniques in mice to develop new treatments for movement disorders.

  • S. Charles Cho, MD

    S. Charles Cho, MD

    Clinical Professor, Adult Neurology
    Clinical Professor (By courtesy), Neurosurgery

    Current Research and Scholarly InterestsClinical research focused on peripheral nerve and muscle disorders. Also involved with prevention of cerebrovascular disesase in the intraoperative setting. Ongoing clincial studies include treatments for Amyotrophic Lateral Sclerosis (ALS), Inflammatory Demyelinating Neuropathy and HIV neuropathic pain.

  • Robert P. Cowan, MD, FAAN, FAHS

    Robert P. Cowan, MD, FAAN, FAHS

    Clinical Professor, Adult Neurology
    Clinical Professor (By courtesy), Anesthesiology, Perioperative and Pain Medicine

    Current Research and Scholarly InterestsCurrent interest focus on patient education technology and patient/physician communication with a particular emphasis on tools which increase encounter efficiency and improve outcomes. Basic research focuses on mechanisms of action in Chronic Daily Headache, with a particular emphasis on New Daily Persistent Headache. Techniques include fMRI, biomarker investigation and evoked potentials. Clinical research includes clinical trials of novel treatments for episodic and chronic headache forms.

  • John W. Day, MD, PhD

    John W. Day, MD, PhD

    Professor of Neurology and Neurological Sciences (Adult Neurology), of Pediatrics (Genetics) and, by courtesy, of Pathology
    On Partial Leave from 02/25/2025 To 08/24/2025

    Current Research and Scholarly InterestsOur Neuromuscular Division coordinates a comprehensive effort to conquer peripheral nerve and muscle disorders, including the muscular dystrophies, motor neuron disorders, neuromuscular junction abnormalities, and peripheral neuropathies. With patients and families foremost in mind, we have had success defining and combating these diseases, with research focused on identifying genetic causes, developing novel treatment, and maximizing patient function by optimizing current management.

  • Jun Ding

    Jun Ding

    Associate Professor of Neurosurgery and of Neurology and Neurological Sciences

    Current Research and Scholarly InterestsNeural circuits of movement control in health and movement disorders

  • Leana Doherty, MD

    Leana Doherty, MD

    Clinical Associate Professor, Adult Neurology

    BioDr. Doherty is a board-certified, fellowship-trained neurologist with Stanford Health Care. She is also a clinical associate professor in the Department of Neurology & Neurological Sciences at Stanford University School of Medicine.

    Dr. Doherty specializes in Guillain-Barre syndrome, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and other neuroinflammatory, neuromuscular, and general neurologic conditions.

    Her research interests include the diagnosis and management of neuromuscular disorders, and quality improvement for inpatient neurologic treatment and management. She has won numerous awards for her research, clinical, and teaching expertise in neurology.

    Dr. Doherty has published in several peer-reviewed journals including Neurology, Neuromuscular Disorders, and Neurology: Neuroimmunology & Neuroinflammation. She has delivered presentations around the country and lectured before an international audience of neurology residents. Dr. Doherty serves as co-associate editor of Annals of Clinical and Translational Neurology (interACTN) and associate editor of New England Journal of Medicine (NEJM) Journal Watch Neurology. She is on the editorial board of The Neurohospitalist.

    Dr. Doherty is a member of the American Academy of Neurology, American Neurological Association, Neurohospitalist Society, and Peripheral Nerve Society.

  • Les Dorfman, MD

    Les Dorfman, MD

    Professor of Neurology and Neurological Sciences, Emeritus

    Current Research and Scholarly InterestsClinical electrophysiology of the peripheral and central nervous systems, including nerve conduction velocity; electromyography (EMG); and visual, auditory and somatosensory evoked potentials. Multiple sclerosis (MS) diagnosis and treatment. Neurological education.

  • Dawn Duane

    Dawn Duane

    Clinical Professor, Pediatric Neurology
    Clinical Professor (By courtesy), Pediatrics

    Current Research and Scholarly InterestsI am a general pediatric neurologist. My interest is in clinical diagnosis and treatment of common neurologic diseases in pediatric patients and teaching feature doctors, neurologists and pediatric neurologists about pediatric neurology.

  • Rachelle Dugue, MD, PhD

    Rachelle Dugue, MD, PhD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Dugue is a board-certified neurologist within the Neurohospitalist Division. She cares for patients at both Stanford Health Care and Stanford Health Care Tri-Valley. She received her MD and PhD at SUNY Downstate Medical Center, where she completed a thesis studying novel treatments for traumatic brain injury. Dr. Dugue then completed her neurology residency at Columbia University Medical Center-New York Presbyterian, followed by a vascular neurology fellowship at Stanford University Hospital.

    Dr. Dugue provides comprehensive, individualized care for patients with a wide range of neurological conditions. She has been recognized for her dedication to excellence in patient care, medical education, and student mentorship.

    Her research interests are centered on acute neurologic care, clinical trials, stroke, and neuroinfectious disease. Dr. Dugue has published in multiple peer-reviewed journals, including The Neurohospitalist, Practical Neurology, Annals of Clinical and Translational Neurology, and Neurology.

  • Shefali Dujari, MD

    Shefali Dujari, MD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Dujari is a board-certified neurologist and fellowship-trained neurohospitalist, specializing in the care of acute neurologic disorders. She practices at both Stanford Hospital and Stanford ValleyCare. She completed her medical training at Boston University, internal medicine preliminary year at California Pacific Medical Center, neurology residency at Stanford University, and neurohospitalist fellowship at Stanford University. She serves as the associate program director of the Stanford Adult Neurology Residency program, the Neurosciences Quality Director at ValleyCare, and the Neurology Resident & Fellow Wellness & Mentoring Committee faculty lead. She has a special interest in medical education and quality improvement.

  • Jeffrey Dunn, MD

    Jeffrey Dunn, MD

    Clinical Professor, Adult Neurology

    Current Research and Scholarly InterestsTranslational research in the human application of emerging immunotherapies for neurological disease, focusing on Multiple Sclerosis, CIS, transverse myelitis and Neuromyelitis Optica (NMO). Collaborative research with Stanford and extramural scientific faculty to identify biomarkers of disease activity and treatment response in humans. Clinical trials to assess efficacy of emerging treatments for MS, CIS and NMO.

  • Margaret S. Ferris, MD

    Margaret S. Ferris, MD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Ferris is a fellowship-trained neurologist and Clinical Assistant Professor in the Department of Neurology, Division of Movement Disorders.

    She diagnoses and treats a breath of movement disorders such as Parkinson’s disease and essential tremor. She recognizes the broad effects of these conditions on daily living and aims to develop personalized, comprehensive treatment plans that optimize health and quality of life.

    Dr. Ferris research interests focus on access to interventional therapies for movement disorders. She has participated in investigations sponsored by the National Institutes of to evaluate advanced treatments for complications of Parkinson’s disease.

    She has co-authored articles in publications such as Nature, The Neurohospitalist, and BioMed Central (BMC) Genomics. She has presented her insights about innovations in the understanding, detection, and management of movement disorders at conferences including, the Society for Neuroscience Annual Meeting, Pan American Parkinson’s Disease and Movement Disorders Congress.

    She is a member of the American Academy of Neurology and the Movement Disorder Society.

    Essential tremor patient story: https://www.youtube.com/watch?v=fV6BzyU9b3c

  • Anna Finley Caulfield, MD

    Anna Finley Caulfield, MD

    Clinical Professor, Adult Neurology

    Current Research and Scholarly InterestsDr. Finley joined the Stanford Stroke Center in 2004 from Beth Israel Deaconess Medical Center in Boston. She cares for acute stroke patients and other neurologically critical ill patients in the intensive care unit. Currently, her research interests include hypothermia after cardiac arrest and comparing health care provider's predications of future neurological function in neurologically critical ill patients to their 6-month outcome.

  • Paul Graham Fisher, MD

    Paul Graham Fisher, MD

    Beirne Family Professor of Pediatric Neuro-Oncology, Professor of Pediatrics and, by courtesy, of Neurosurgery and of Epidemiology and Population Health
    On Partial Leave from 07/15/2024 To 07/13/2025

    Current Research and Scholarly InterestsClinical neuro-oncology: My research explores the epidemiology, natural history, and disease patterns of brain tumors and other cancers in childhood, as well as prospective clinical trials for treating these neoplasms. Research interests also include neurologic effects of cancer and its therapies.

  • Robert Fisher, MD, PhD

    Robert Fisher, MD, PhD

    The Maslah Saul, MD, Professor and Professor, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsDr. Fisher is interested in clincal, laboratory and translational aspects of epilepsy research. Prior work has included: electrical deep brain stimulation for epilepsy, studied in laboratory models and clinical trials; drug delivery to a seizure focus; mechanisms of absence epilepsy studied with in vitro slices of brain thalamus; hyperthermic seizures; diagnosis and treatment of non-epileptic seizures, the post-ictal state; driving and epilepsy; new antiepileptic drugs; surgery for epilepsy.

  • Andrea Fuentes

    Andrea Fuentes

    Clinical Assistant Professor, Adult Neurology

    BioDr. Fuentes is a board-certified neurologist with the Movement Disorders Center at Stanford Health Care. She is also a clinical assistant professor in the Department of Neurology and Neurological Sciences. Dr. Fuentes completed a movement disorders fellowship at the University of California, San Francisco.

    She provides comprehensive care for patients with different types of movement disorders, including Parkinson’s disease (PD), atypical parkinsonian disorders, essential tremor, ataxia, dystonia, and chorea. As part of her clinical practice, she performs deep brain stimulation (DBS) evaluation and programming and botulinum toxin injections.

    Her research efforts include several clinical trials assessing treatments for movement disorders. She has been a sub-investigator on multiple trials evaluating drug candidates for the treatment of PD and ataxia. She has presented her work at national and international meetings, including those for the International Parkinson and Movement Disorder Society and the American College of Physicians.

    Dr. Fuentes is a member of the American Academy of Neurology and the International Parkinson and Movement Disorder Society.

  • Kristin Galetta, MD

    Kristin Galetta, MD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Galetta is a board-certified neurologist within the Neurohospitalist and Neuroimmunology divisions. She completed a multiple sclerosis (MS) fellowship at Brigham and Women’s Hospital.

    She has extensive experience diagnosing and treating patients with autoimmune neurologic conditions including multiple sclerosis, optic neuritis, autoimmune encephalitis and transverse myelitis. Her research interests are focused on understanding best treatment strategies for patients with multiple sclerosis and more rare autoimmune neurologic conditions. She also has an interest in medical education improvement.

    She has published in numerous peer-reviewed journals, including the Journal of Neurological Sciences and Multiple Sclerosis and Related Disorders. She is a peer reviewer for multiple prestigious journals, including Neurology and Frontiers in Neurology.

  • Paul George, MD, PhD

    Paul George, MD, PhD

    Associate Professor of Neurology and Neurological Sciences (Adult Neurology) and, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsCONDUCTIVE POLYMER SCAFFOLDS FOR STEM CELL-ENHANCED STROKE RECOVERY:
    We focus on developing conductive polymers for stem cell applications. We have created a microfabricated, polymeric system that can continuously interact with its biological environment. This interactive polymer platform allows modifications of the recovery environment to determine essential repair mechanisms. Recent work studies the effect of electrical stimulation on neural stem cells seeded on the conductive scaffold and the pathways by which it enhances stroke recovery Further understanding the combined effect of electrical stimulation and stem cells in augmenting neural repair for clinical translational is a major focus of this research going forward.

    BIOPOLYMER SYSTEMS FOR NEURAL RECOVERY AND STEM CELL MODULATION:
    The George lab develops biomaterials to improve neural recovery in the peripheral and central nervous systems. By controlled release of drugs and molecules through biomaterials we can study the temporal effect of these neurotrophic factors on neural recovery and engineer drug delivery systems to enhance regenerative effects. By identifying the critical mechanisms for stroke and neural recovery, we are able to develop polymeric technologies for clinical translation in nerve regeneration and stroke recovery. Recent work utilizing these novel conductive polymers to differentiate stem cells for therapeutic and drug discovery applications.

    APPLYING ENGINEERING TECHNIQUES TO DETERMINE BIOMARKERS FOR STROKE DIAGNOSTICS:
    The ability to create diagnostic assays and techniques enables us to understand biological systems more completely and improve clinical management. Previous work utilized mass spectroscopy proteomics to find a simple serum biomarker for TIAs (a warning sign of stroke). Our study discovered a novel candidate marker, platelet basic protein. Current studies are underway to identify further candidate biomarkers using transcriptome analysis. More accurate diagnosis will allow for aggressive therapies to prevent subsequent strokes.

  • Carl Gold

    Carl Gold

    Clinical Associate Professor, Adult Neurology
    Clinical Associate Professor (By courtesy), Neurosurgery

    BioDr. Gold is a board-certified neurologist who is fellowship-trained in the diagnosis and treatment of neurological disorders in hospitalized patients. He cares for a broad range of patients, including individuals with seizures, central nervous system infections, autoimmune diseases, headaches, neuromuscular conditions, and neurological complications of cancer.

    Dr. Gold serves as Vice Chair of Quality, Safety, & Experience for the Department of Neurology & Neurological Sciences. In this role, he coordinates projects aimed at improving care for patients with neurological conditions across the health system. He also serves as Medical Director of Service Excellence for Stanford Health Care.

    For more information on the Stanford Neurohospitalist Program & Fellowship, please visit: https://med.stanford.edu/neurology/divisions/neurohospitalist.html
    Learn more about the Stanford Neurology Communication Coaching Program by visiting: http://med.stanford.edu/neurology/education/resident-coaching.html
    Additional information on Stanford Neurology's efforts in Quality, Safety, & Value can be found here: http://med.stanford.edu/neurology/quality.html

  • Olga Fedin Goldberg

    Olga Fedin Goldberg

    Clinical Associate Professor, Adult Neurology

    BioDr. Goldberg is board-certified in Neurology by the American Board of Psychiatry and Neurology. She provides comprehensive neurologic care to patients with a broad range of neurologic conditions, including those who have multiple neurologic conditions. She is interested in medical education for neurology residents and for referring primary care providers and serves as Director of Neurology Resident Continuity Clinic. Additionally, she completed the Stanford CELT (Clinical Education Leadership Training) Program for developing skills in quality improvement. She has led or played a key role in multiple quality improvement projects in the Department of Neurology, including those focused on increasing patient understanding of their neurologic medications upon hospital discharge, improvement of outcomes for headache patients seen in primary care, and in optimizing clinic processes involved in collection of cerebrospinal fluid.

  • Neelam Goyal, MD

    Neelam Goyal, MD

    Clinical Professor, Adult Neurology

    Current Research and Scholarly InterestsDr. Goyal's research interests involve monitoring and managing the short and long-term toxicity of immunosuppressive agents used in the treatment of immune-mediated neuromuscular disorders. She is actively involved in a grant-supported project investigating steroid toxicity in patients with myasthenia gravis.

    She also serves as the Wellbeing Co-Director for the Neurology Department, working on a grant-supported project aimed at mitigating the adverse impact of work on personal relationships.

  • Maxwell Greene, MD

    Maxwell Greene, MD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Greene is a board-certified, fellowship-trained neurologist. He is also a Clinical Assistant Professor of Neurology at Stanford University School of Medicine.

    Dr. Greene provides clinical care for adult patients with disorders of the muscles and peripheral nerves that cause weakness and numbness. He specializes in diagnosing and treating neuromuscular diseases that include amyotrophic lateral sclerosis (ALS), all types of muscular dystrophy, chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, and Charcot-Marie-Tooth (CMT). For CIDP and CMT, Stanford is one of the few centers of excellence in the country.

    A significant part of Dr. Greene’s practice involves investigational work, where he seeks to determine the cause of a patient’s symptoms. In addition to performing the full range of diagnostic tests including interpreting biopsy procedures, he has special qualifications in electrodiagnosis and the use of electromyography and nerve conduction studies.

    Treatments offered by Dr. Greene cover the complete spectrum of options, with an emphasis on immune therapies for certain conditions. For CIDP and myasthenia gravis, he administers immune globulin, steroids, plasmapheresis, and rituximab. To help manage symptoms of CMT and support areas of the body weakened by this disease, he can recommend physical therapy, occupational therapy, and foot, ankle, and knee orthotics.

    For the treatment of ALS and muscular dystrophy, Dr. Greene leads a multidisciplinary team offering physical and occupational therapy, pulmonary expertise, speech and swallow expertise, nutrition counseling, social services, and specialized nursing, and works together with genetic counseling. All team members collaborate closely to ensure patients receive the care and comfort needed to meet their emotional as well as physical needs.

    As part of his commitment to advancing patients’ treatment options, Dr. Greene conducts clinical research. Among his current interests are
    innovative new therapies for ALS and other nerve and muscular disorders. This is an exciting time in the field of neuromuscular medicine, with real potential for treatment breakthroughs for the first time in decades. Exploring these new directions enables Dr. Greene to offer Stanford patients access to options that may not be available anywhere else.

    To highlight new advances for his peers, Dr. Greene has made national and regional presentations at conferences including the American Academy of Neurology meeting. Topics include the results of a study supported in part by the National Institutes of Health: paraneoplastic antibodies as markers of Hodgkin’s disease. JAMA Neurology published Dr. Greene’s article on this research.

    Dr. Greene’s achievements have earned recognition from the American Academy of Neurology and other organizations. He is also the recipient of a travel award from the American Neurological Association and a grant from the NIH National Institute of Neurological Disorders and Stroke.

    A member of the American Academy of Neurology, Dr. Greene is also an active member of the Western ALS Consortium and Northeastern ALS Consortium.

  • Michael Greicius, MD, MPH

    Michael Greicius, MD, MPH

    Iqbal Farrukh and Asad Jamal Professor and Professor, by courtesy, of Psychiatry and Behavioral Sciences (Administrative and Academic Special Programs)

    Current Research and Scholarly InterestsAs the Founding Director of the Stanford Center for Memory Disorders and Principal Investigator of a lab focused on the genetics of Alzheimer's disease (AD), Dr. Greicius' research focuses on elucidating the neurobiologic underpinnings of AD. His lab combines cutting edge brain imaging, "deep" phenotyping, and whole-genome sequencing of human subjects to identify novel pathways involved in AD pathogenesis. The goal of his work is to develop effective treatment for AD patients.

  • Jin S. Hahn, MD

    Jin S. Hahn, MD

    Professor of Neurology at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly Interests1. Clinical informatics and electronic health records
    2. Neonatal and fetal neurology
    3. Prenatal diagnosis neurodevelopmental anomalies
    4. Personalized Health and Wellness Records

  • May Han, MD

    May Han, MD

    Associate Professor of Neurology and Neurological Sciences (Adult Neurology)

    Current Research and Scholarly InterestsMultiple sclerosis
    Neuromyelitis optica
    Autoimmune CNS disorders

  • Melanie Hayden Gephart

    Melanie Hayden Gephart

    Professor of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences

    BioI am a brain tumor neurosurgeon, treating patients with malignant and benign tumors, including gliomas, brain metastases, meningiomas, and schwannomas. I direct the Stanford Brain Tumor Center and the Stanford Brain Metastasis Consortium, collaborative unions of physicians and scientists looking to improve our understanding and treatment of brain tumors. My laboratory seeks greater understanding of the mechanisms driving tumorigenesis and disease progression in malignant brain tumors. We study how rare cancer cell populations survive and migrate in the brain, inadvertently supported by native brain cells. We develop novel cerebrospinal fluid-based biomarkers to track brain cancer treatment response, relapse, and neurotoxicity. Our bedside-to-bench-to-bedside research model builds on a foundation of generously donated patient samples, where we test mechanisms of brain cancer growth, develop novel pre-clinical models that reliably recapitulate the human disease, and facilitate clinical trials of new treatments for patients with brain cancer.

    www.GephartLab.com
    https://stan.md/BrainMets
    @HaydenGephartMD

  • Jaimie Henderson, MD

    Jaimie Henderson, MD

    John and Jene Blume - Robert and Ruth Halperin Professor, Professor of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences

    Current Research and Scholarly InterestsMy research interests encompass several areas of stereotactic and functional neurosurgery, including frameless stereotactic approaches for therapy delivery to deep brain nuclei; cortical physiology and its relationship to normal and pathological movement; brain-computer interfaces; and the development of novel neuromodulatory techniques for the treatment of movement disorders, epilepsy, pain, and other neurological diseases.

  • Victor W. Henderson, MD, MS

    Victor W. Henderson, MD, MS

    Professor of Epidemiology and Population Health and of Neurology and Neurological Sciences

    Current Research and Scholarly InterestsResearch interests:
    (1) Risk factors for age-associated cognitive decline and for dementia.
    (2) Therapeutic strategies to improve cognitive abilities in aging and in dementia.
    (3) Brain–behavior relations as they pertain to human cognition.

  • Karen G. Hirsch, MD

    Karen G. Hirsch, MD

    Professor of Neurology and Neurological Sciences (Adult Neurology)

    Current Research and Scholarly InterestsDr. Karen G. Hirsch cares for critically ill patients with neurologic disorders in the intensive care unit. Dr. Hirsch's research focuses on using continuous and discrete multi-modal data to develop phenotypes and identify signatures of treatment responsiveness in patients with coma after cardiac arrest. She is the Co-PI of PRECICECAP (PRecision Care In Cardiac ArrEst - ICECAP, NINDS R01 NS119825-01). The research team works closely with collaborators in data science at Stanford and with industry partners to apply machine learning analyses to complex multi-modal ICU data. Dr. Hirsch also studies neuro-imaging in post-cardiac arrest coma and traumatic brain injury, and with colleagues in Cardiac Anesthesia and Cardiothoracic Surgery, Dr. Hirsch studies neurologic outcomes in patients on mechanical circulatory support including ECMO.

    Along with colleagues in Biomedical Ethics, Dr. Hirsch studies brain death, organ donation, and neuroethics. She is the Co-PI of BCI-DEF (Brain Computer Interfaces and Disability: Developing an Inclusive Ethical Framework, NIMH 1R01MH130518-01) which is a BRAIN Initiative funded study that is qualitatively evaluating end user perspectives about the benefits, risks, and ethical challenges of Brain Computer Interfaces for patients with acute stroke or traumatic brain injury.

    Dr. Hirsch is broadly interested in improving neurologic outcomes after acute severe brain injury, identifying early phenotypes to guide precision medicine in neurocritical care, and exploring ethical issues in neurocritical care and novel neurotechnology. Dr. Hirsch greatly appreciates the importance of team science and collaboration.

  • John Hotson

    John Hotson

    Professor (Clinical) of Neurology and Neurological Sciences, Emeritus

    Current Research and Scholarly InterestsThe response and recovery of human visual cortex, oculomotor systems and related cognitive functions after acquired neurological disorders is a main area of interest.

  • Ting-Ting Huang

    Ting-Ting Huang

    Associate Professor (Research) of Neurology (Adult Neurology), Emerita

    Current Research and Scholarly InterestsWe study the role of oxygen free radicals in oxidative tissue damage and degeneration. Our research tools include transgenic and knockout mice and tissue culture cells for in vitro gene expression.

  • John Huguenard

    John Huguenard

    Professor of Neurology and Neurological Sciences (Neurology Research), of Neurosurgery (Adult Neurosurgery) and, by courtesy, of Molecular and Cellular Physiology
    On Leave from 02/16/2025 To 02/15/2026

    Current Research and Scholarly InterestsWe are interested in the neuronal mechanisms that underlie synchronous oscillatory activity in the thalamus, cortex and the massively interconnected thalamocortical system. Such oscillations are related to cognitive processes, normal sleep activities and certain forms of epilepsy. Our approach is an analysis of the discrete components (cells, synapses, microcircuits) that make up thalamic and cortical circuits, and reconstitution of components into in silico computational networks.

  • Michelle L. James

    Michelle L. James

    Associate Professor of Radiology (Molecular Imaging Program at Stanford) and of Neurology and Neurological Sciences (Neurology Research)

    Current Research and Scholarly InterestsThe primary aim of my lab is to improve the diagnosis and treatment of brain diseases by developing translational molecular imaging agents for visualizing neuroimmune interactions underlying conditions such as Alzheimer’s disease, multiple sclerosis, and stroke.

  • Safwan Jaradeh, MD

    Safwan Jaradeh, MD

    Professor of Neurology and Neurological Sciences (Adult Neurology) and, by courtesy, of Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsClinical interests include autonomic disorders, small fiber neuropathies and the development of effective methods of testing and treating these disorders. Prior work has focused on small fiber painful and autonomic neuropathies; syndromes of orthostatic intolerance and syncope; gastrointestinal motility dysfunction; cyclic vomiting; protacted Gastroesophageal Reflux; non-allergic rhinitis syndromes; and the relationship between the autonomic nervous system and normal or abnormal sleep. Additional areas of interest include the neurology of phonation and swallowing disorders, and peripheral nerve injury and repair.

  • Susy Jeng

    Susy Jeng

    Clinical Associate Professor, Pediatric Neurology
    Clinical Associate Professor, Pediatrics

    BioDr. Susy Jeng is Clinical Associate Professor of Neurology at Stanford Children’s Hospital at Stanford University. Dr. Jeng received her A.B. at Harvard College and M.D. at the University of California, San Diego. She completed her pediatrics residency at University of California, San Francisco and is board-certified in pediatrics. After practicing general pediatrics for two years, she returned to UCSF for neurology residency. Upon completion of her residencies, she joined the faculty at Stanford as a general child neurologist with a special interest in medical education. She is the site director for the Stanford medical student neurology clerkship and the pediatric neurology liaison to the Stanford pediatrics residency program.

  • Jocelyn Jiao, MD

    Jocelyn Jiao, MD

    Clinical Assistant Professor, Adult Neurology
    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioDr. Jiao is a fellowship-trained, board-certified neurologist with the Movement Disorders Center at Stanford Health Care. She is also a clinical assistant professor in the Department of Neurology and Neurological Sciences.

    Dr. Jiao has extensive experience providing comprehensive care for patients with different types of movement disorders, including Parkinson’s disease. She is fellowship-trained in both movement disorders and hospice and palliative medicine. Dr. Jiao is developing an interdisciplinary neuropalliative clinic that emphasizes planning for the future and maximizes quality of life for people living with chronic neurological illness.

    Dr. Jiao’s research efforts include a pilot study assessing the impact of deep brain stimulation (DBS) as a treatment for Parkinson’s-related motor symptoms upon mood and pain. Specifically, this work focuses on identifying correlations between DBS targets and reductions in medications that address depression, anxiety, and impulsivity symptoms that result from Parkinson’s treatments. Dr. Jiao has also completed a pilot study focused upon narrative medicine interventions for people living with Parkinson’s disease.

    Dr. Jiao has published her work in multiple peer-reviewed journals, including Pain Medicine and the Journal of Neurosurgery. Dr. Jiao is a member of the American Academy of Neurology, the International Parkinson and Movement Disorder Society , and the International Neuropalliative Care Society.

  • Tahereh Kamali

    Tahereh Kamali

    Instructor, Adult Neurology

    Current Research and Scholarly InterestsAI for Healthcare, Neuroimaging, Biomarkers Development

  • Lucas Kipp

    Lucas Kipp

    Clinical Associate Professor, Adult Neurology

    BioDr. Kipp specializes in the diagnosis and treatment of neuroimmunological disorders, particularly demyelinating conditions such as multiple sclerosis and neuromyelitis optica. He is interested in translational research connecting expert MS clinicians, world-renown immunology laboratories, and advanced neuroimaging techniques to identify biomarkers of disease and treatment response.

  • Hannah Louise Kirsch, MD

    Hannah Louise Kirsch, MD

    Clinical Assistant Professor, Adult Neurology

    BioHannah Louise Kirsch, MD is a board-certified neurologist and a Clinical Assistant Professor in the Neurocritical Care Division of the Department of Neurology & Neurological Sciences at Stanford University School of Medicine.

    Dr. Kirsch is also a hospitalist who pays special attention to delivering Stanford Health Care patients the best possible neurological care.

    She serves on the National Institute of Neurological Disorders and Stroke committee dedicated to coma and conditions related to consciousness. She has implemented numerous neurology-centered educational activities for health care professionals from diverse specialties, including training psychiatrists on the neuropsychiatric complications of COVID-19. She also has helped educate oncologists and hematologists regarding common neurological conditions among cancer patients.

    Dr. Kirsch has conducted research on a range of topics, including thrombotic complications in critically ill COVID-19 patients, advances in intracranial pressure monitoring, and predictors of outcomes in acute encephalitis. She has published her findings in Neurology, the Journal of Trauma, Emergency Medicine, and Procedures, among other journals.

    She has given presentations on topics including variations in coagulation among patients with cerebral hemorrhage and the association of cerebral pressure with cardiac arrest. She has shared her discoveries at meetings of the Neurocritical Care Society and Society of Hospital Medicine.

    The Neurocritical Care Society has honored her work. She also won the prestigious Leonard Tow Humanism in Medicine Award, which recognizes clinical excellence, outstanding compassion in the delivery of care, and respect for patients, families, and health care colleagues.

    Dr. Kirsch received her medical degree from New York University. She completed her residency in neurology at the University of California, San Francisco, and a fellowship in neurocritical care at Columbia University. She also completed the Columbia University narrative medicine certificate program and is board certified in neurology by the American Board of Psychiatry and Neurology.

  • Juliet Klasing Knowles

    Juliet Klasing Knowles

    Assistant Professor of Neurology and Neurological Sciences (Pediatric Neurology) and of Pediatrics

    Current Research and Scholarly InterestsThe Knowles lab studies how white matter structure changes in different forms of epilepsy, and how aberrant white matter structure, in turn, shapes neuronal network function. In mouse models, we use a variety of innovative tools including neurophysiology, quantitative EEG, behavior, histological measures of white matter structure and MR imaging. We also conduct clinical research to study white matter abnormalities in children with epilepsy.

  • Lironn Kraler, MD

    Lironn Kraler, MD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Kraler is a board-certified neurologist with subspecialty training in vascular neurology, and a Clinical Assistant Professor at Stanford University School of Medicine. Dr. Kraler is also the Associate Program Director for the Vascular Neurology Fellowship at Stanford.

    Before joining the faculty at Stanford, Dr. Kraler attended medical school at Keck School of Medicine at the University of Southern California where she was elected to the Alpha Omega Alpha National Honor Society. She completed her residency training at Stanford Hospital where she served as chief resident, followed by her Vascular Neurology fellowship training at Stanford. She then completed a post-doctoral research fellowship at Stanford University’s Clinical Excellence Research Center (CERC) focused on addressing the high cost of care in US Hospitals.

    Her research interests include improving access and quality of population health and developing high-value innovations in care delivery that decrease the cost of care while improving the quality to patients. In addition, she has a strong interest in medical education. Dr. Kraler has received recognition for outstanding medical student teaching from the Department of Neurology.

  • Prashanth Krishnamohan, MD

    Prashanth Krishnamohan, MD

    Clinical Associate Professor, Adult Neurology
    Clinical Associate Professor (By courtesy), Neurosurgery

    BioDr. Krishnamohan is a board-certified, fellowship-trained neurologist. He is a clinical assistant professor of neurology and neurological sciences and, by courtesy, of neurosurgery at Stanford University School of Medicine. In addition, he is Medical Director of the Neurosciences Service Line at Stanford Health Care – ValleyCare and is Medical Director of its Stroke program.

    Dr. Krishnamohan excels in the diagnosis and treatment of neurological conditions. His clinical interests include the management of stroke, epilepsy, concussion, and coma. With every patient, his goal is to provide personalized care designed to optimize neurological function for the best possible clinical outcome and quality of life.

    He has published extensively on topics including innovations in stroke care quality management and measurement, rapid bedside evaluation of seizures in the ICU, and EEG metrics in comatose cardiac arrest patients. Articles by Dr. Krishnamohan have appeared in Neuroanesthesia and Neurocritical Care, Quality Management in Healthcare, Current Infectious Disease Reports, and other journals. He has presented his research findings at the annual meetings of the Neurocritical Care Society and American Academy of Neurology.
    He has authored chapters on post-concussive syndrome, stroke, and other conditions for the guidebook Ferri’s Clinical Advisor. In addition, he is a reviewer for the Journal of Neuroscience Nursing, Neurohospitalist, and the Journal of Neurology, Neurosurgery, and Psychiatry.

    Dr. Krishnamohan has won recognition from Stanford Health Care, the Institute for Healthcare Improvement Open School, the University of Kentucky College of Medicine, and PSG Institute of Medical Sciences and Research – the latter two his alma maters.

    Dr. Krishnamohan is a member of the Neurocritical Care Society, American Academy of Neurology, and American Heart Association/American Stroke Association. He volunteers as a community health educator with numerous organizations.

  • Kathryn Kvam

    Kathryn Kvam

    Clinical Associate Professor, Adult Neurology
    Clinical Associate Professor (By courtesy), Neurosurgery

    Current Research and Scholarly InterestsDr. Kvam's research focuses on 1) how to measure quality of care for patients with neurologic disease, 2) the value and impact of neurohospitalist models of care on patient outcomes and trainee education and 3) outcomes in rare diseases like autoimmune encephalitis.

  • Maarten Lansberg, MD, PhD

    Maarten Lansberg, MD, PhD

    Professor of Neurology and Neurological Sciences (Adult Neurology) and, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsMy research involves the design and conduct of clinical trials to discover new treatments for patients who have suffered a stroke. These trials span treatment of acute stroke, stroke recovery, and stroke prevention. My research in acute stroke is primarily focused on the use of advanced neuroimaging methods (CT and MRI) to select patients who are most likely to benefit from therapies aimed at restoring blood flow to the brain in patients who have suffered a stroke.

  • Nicholas Wiessner Larsen, MD

    Nicholas Wiessner Larsen, MD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Larsen is a clinical assistant professor in the Department of Neurology, Division of Autonomic Disorders. He is a board-certified neurologist and a fellowship-trained specialist in neurophysiology and autonomics. He completed medical school at the University of Utah and neurology residency and fellowship at Stanford.

    In his clinical practice, Dr. Larsen focuses on disorders of the autonomic nervous system (ANS). His research interest is in the long-term autonomic complications of COVID-19. He is the principal investigator of a study looking at post-COVID postural tachycardia syndrome.

    Dr. Larsen’s research interests also include Global Health Neurology. Dr. Larsen helped establish the first stroke unit in Rwanda and is part of the American Academy of Neurology’s Refugees & Asylum Seekers Working Group.

    He has co-authored articles for publication in Clinical Autonomic Research, Autonomic Neuroscience, Nature Climate Change, and elsewhere. He is a recipient of the American Academy of Neurology Medical Student Prize for Excellence as well as a member of the Alpha Omega Alpha Honor Medical Society.

  • Amira Latif Hernandez

    Amira Latif Hernandez

    Instructor, Adult Neurology

    BioAmira obtained her Ph.D. in Neuroscience from the KU Leuven, Belgium, in summer 2017. During her doctoral studies, she used clinically valid tests of murine cognition, neuronal plasticity measures in hippocampal and cortical slices, brain lesion methods, pharmacological applications and resting state functional magnetic resonance imaging to characterize the pathophysiology of novel mouse models of Alzheimer’s disease (AD). One of her most gratifying contributions was the development of a new electrophysiology tool to assess synaptopathies, and the establishment of long-term synaptic plasticity from prefrontal cortex of APP knock-in mice. In Autumn 2017, she moved to Dr. Longo’s lab at the Stanford School of Medicine, where she investigates signaling pathways involved in synaptic degeneration. During 3 years of postdoctoral work, she established a multi-electrode array system with eight independent recording chambers that allows high-throughput analyses of multiple long-lasting forms of synaptic plasticity. She also gained experience in RNA-sequencing, molecular biochemistry, signaling mechanisms, target validation and drug development strategies for AD. In October 2020, Amira has been appointed as an Instructor in Neurodegenerative Disease Research, in the Longo lab, to help develop improved and more powerful approaches that will better reveal key synaptic mechanisms and candidate modules associated with neuroplasticity and affected in AD mouse models, by identifying activity-dependent gene expression signatures.

  • Scheherazade Le, MD

    Scheherazade Le, MD

    Clinical Professor, Adult Neurology

    Current Research and Scholarly InterestsNeurophysiology, Epilepsy/EEG, Intraoperative Neurophysiologic Monitoring,Tuberous Sclerosis, Autoimmune Epilepsy/Encephalitis, Autoimmune Encephalitis, Immune-Mediated Epilepsy

  • Christopher Lee-Messer, MD, PhD

    Christopher Lee-Messer, MD, PhD

    Clinical Associate Professor, Pediatric Neurology
    Clinical Associate Professor (By courtesy), Pediatrics

    Current Research and Scholarly InterestsMy chief clinical focus is in pediatric epilepsy, especially how epilepsy affects learning and development. For my research, I background in neural development and computational neuroscience towards developing better learning algorithms and applying the latest techniques in machine learning for better diagnosis and treatment of disease.

  • Kenneth Leung, MD, MS

    Kenneth Leung, MD, MS

    Clinical Assistant Professor, Adult Neurology

    BioDr. Leung is a board-certified neurologist who practices both comprehensive neurology and neuromuscular medicine. He is a Clinical Assistant Professor in the Department of Neurology within the Stanford University School of Medicine.

    Dr. Leung has a particular interest in the diagnosis and management of a broad range of disorders affecting muscle and nerves, including motor neuron disease, neuropathy, neuromuscular junction disorders, and myopathy. He also is an avid clinician educator who develops course work, is involved in education research, and teaches medical students and neurology residents/fellows. He currently serves as Director of the Neurology Clerkship for medical students and Associate Director of the Neuromuscular Medicine Fellowship within the Stanford University School of Medicine.

    He earned his bachelor’s degree from the University of California, Berkeley where he was awarded the 2011 Departmental Citation Award for Excellence in Research in Immunology. In 2016 he earned his medical degree and concurrent master’s degree in applied anatomy from Case Western Reserve University School of Medicine. He then completed his internal medicine internship at Santa Clara Valley Medical Center and neurology residency at the Mount Sinai Hospital in New York. During this time, he developed a passion for neurology education and served on graduate medical education committees for curricular development, trainee well-being and resilience, and quality improvement. For his work in medical education, he was selected as a Harvard Macy Institute Scholar in 2018 and was awarded the 2020 Institute for Medical Education House Staff Excellence in Teaching Award. He was also inducted as a house staff in the Alpha Omega Alpha honor society. He then went on to complete a neuromuscular medicine fellowship at Stanford prior to joining as faculty.-

  • Gordon Li, MD

    Gordon Li, MD

    Professor of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences and of Otolaryngology - Head & Neck Surgery (OHNS)

    Current Research and Scholarly Interests1.) My laboratory studies the biology of brain tumors with the goal of developing novel therapeutics for the treatment of malignant brain tumors and translating that research into clinical trials.
    2.) My clinical interests include improving surgical techniques for brain tumor surgery, immunotherapy for the treatment of glioblastoma, and novel uses for stereotactic radiosurgery.

  • Y. Joyce Liao, MD, PhD

    Y. Joyce Liao, MD, PhD

    Stanford Medicine Professor of Ophthalmology and Professor of Neurology and Neurological Sciences

    Current Research and Scholarly InterestsIschemic optic neuropathy
    Stem cell transplantation
    Optic neuropathy
    Optic neuritis
    Eye movement disorders
    Reading
    Parkinson's disease
    Multiple sclerosis

  • Michael Lim, M.D.

    Michael Lim, M.D.

    Stanford Medicine Endowed Chair of the Department of Neurosurgery, Professor of Neurosurgery and, by courtesy, of Radiation Oncology, of Medicine, of Otolaryngology - Head & Neck Surgery (OHNS) and of Neurology and Neurological Sciences

    BioDr. Lim is the Chair of the Department of Neurosurgery and a board-certified neurosurgeon specializing in brain tumors and trigeminal neuralgia.

    Dr. Lim’s clinical interests include the treatment of benign and malignant brain tumors, with special interest in gliomas, meningiomas, metastatic tumors, and skull base tumors. Dr. Lim also specializes in surgical treatments for trigeminal neuralgia. During his time at Johns Hopkins, Dr. Lim built one of the largest brain tumor and trigeminal neuralgia practices and utilized the most advanced surgical technologies and techniques for his patients. As a passionate voice for patient experience, he has been recognized by his peers and patients for his integrity and compassionate care, including a Service Excellence Award from HealthNetwork Foundation.

    As a mentor, he has garnered numerous teaching awards, including being honored as an outstanding teacher by Johns Hopkins University School of Medicine. He is actively involved in shaping education for neurosurgery and oncology across the United States and around the world. He is the recipient of the prestigious 2023 Abhijit Guha Award in Neuro-Oncology.

    Dr. Lim’s research interests focus on harnessing the immune system to fight cancer. His laboratory focuses on understanding mechanisms of immune evasion by cancer cells. He has successfully translated his findings from the laboratory to the clinics and has conducted and led several large national immunotherapy clinical trials for brain tumors.

    Dr. Lim’s bibliography contains well over 300 articles on topics such as immunotherapy for glioblastoma, long-term survival of glioma patients treated with stereotactic radiation, and treatment of neuropathic pain. His work has appeared in Science Translational Medicine, Clinical Cancer Research, Lancet Oncology, Nature Immunology, and many more publications. He also has written 20 book chapters and monographs.

    Dr. Lim is a world leader in immunotherapy for brain tumors. In addition to being invited world-wide to give lectures and seminars, he has given platform presentations on the topics of immunotherapy for brain tumors, neurosurgical techniques and management of brain tumors at the American Society of Clinical Oncologists, American Academy of Neurological Surgeons, Radiological Society of North America, Annual Symposium on Brain and Spine Metastases, Congress of Neurological Surgeons, and other meetings. In addition, he has served as platform chairman of the CNS session at the American Society for Clinical Oncology conference.

    Dr. Lim is a member of the American Society for Clinical Oncology, Congress of Neurological Surgeons, American Association of Neurological Surgeons, and Society for Neuro-Oncology. Dr. Lim served as the program co-chair of the Society for Neuro-Oncology and CNS section of the American Society for Clinical Oncology. He also served on many executive committees, including the Executive Committee for the Joint Tumor Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons.

    Trigeminal neuralgia treatment: https://www.youtube.com/watch?v=-n8nvwkwZik

    Trigeminal neuralgia patient stories: https://www.youtube.com/watch?v=kClePRPYlQs&t=1s

  • Kathie S Lin

    Kathie S Lin

    Clinical Assistant Professor, Adult Neurology

    BioDr. Kathie Lin is an Assistant Professor of Neurology and Neurological Sciences at Stanford University. She is board certified in Neurology and Neuromuscular Medicine after completing her residency at Harvard Neurology Program at the Beth Israel Deaconess Medical Center in Boston and advanced fellowship training at Stanford. She practices both Neuromuscular Medicine and Comprehensive Neurology in Emeryville and Palo Alto. She has a particular interest in the diagnosis and management of neuromuscular disease including neuromuscular junction disorders, motor neuron disease, and focal neuropathy. Additionally, she is interested in medical education and developing a practical framework for teaching neurology and neurophysiology to medical students and neurology residents.

    She is the Neuromuscular Division teaching lead, arranging neuromuscular education for neurology residents. She is also an Assistant Program Director of the Stanford Adult Neurology Residency Program.

  • Frank M. Longo, MD, PhD

    Frank M. Longo, MD, PhD

    George E. and Lucy Becker Professor of Medicine and Professor, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsClinical interests include Alzheimer's disease and Huntington's disease and the development of effective therapeutics for these disorders. Laboratory interests encompass the elucidation of signaling mechanisms relevant to neurodegenerative disorders and the development of novel small molecule approaches for the treatment of neurodegenerative and other neurological disorders.

  • Jaime Lopez, MD

    Jaime Lopez, MD

    Professor of Neurology and Neurological Sciences (Adult Neurology) and, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsMy clinical interests are in the areas of Intraoperative Neurophysiologic Monitoring (IOM), clinical neurophysiology, electromyopgraphy and in the use of botulinum toxins in the treatment of neurologic disorders. Our IOM group’s research is in the development of new and innovative techniques for monitoring the nervous system during surgical and endovascular procedures and how these alter surgical management and patient outcomes. I am also active in formulating national IOM practice guidelines.

  • Sean Mackey, M.D., Ph.D.

    Sean Mackey, M.D., Ph.D.

    Redlich Professor, Professor of Anesthesiology, Perioperative, and Pain Medicine (Adult Pain) and, by courtesy, of Neurology and Neurological Sciences

    Current Research and Scholarly InterestsMultiple NIH funded projects to characterize CNS mechanisms of human pain. Comparative effectiveness of cognitive behavioral therapy and chronic pain self-management within the context of opioid reduction (PCORI funded). Single session pain catastrophizing treatment: comparative efficacy & mechanisms (NIH R01). Development and implementation of an open-source learning healthcare system, CHOIR (http://choir/stanford.edu), to optimize pain care and innovative research in real-world patients.

  • William J Marks, Jr., MD, MS-HCM

    William J Marks, Jr., MD, MS-HCM

    Adjunct Clinical Professor, Adult Neurology

    BioDr. Marks is the Chief Medical Officer and Co-Founder of Nexus NeuroTech, dedicated to advancing breakthrough technologies for brain disorders.

    Dr. Marks received an Honors Bachelor of Science degree in Biology from Marquette University and his Medical Degree from the Johns Hopkins University School of Medicine. He completed his neurology residency and fellowship at the University of California, San Francisco (UCSF). Dr. Marks also holds a Master of Science in Health Care Management degree from the Harvard School of Public Health.

    Dr. Marks is Board Certified in Neurology and Clinical Neurophysiology. Prior to joining the Stanford Faculty, he served as Professor of Neurology at UCSF. His clinical and research interests include movement disorders, epilepsy, neuromodulation, health technology, and health care policy.

    Dr. Marks previously served as Head of Clinical Science at Verily Life Sciences, formerly Google Life Sciences, and now is an Advisor in Neurology for Verily.

  • Jamie McDonald, MD, MS

    Jamie McDonald, MD, MS

    Clinical Assistant Professor, Adult Neurology

    BioDr. McDonald is a fellowship-trained, board-certified neurologist and clinical assistant professor in the Department of Neurology at Stanford University School of Medicine.

    She specializes in the diagnosis and treatment of multiple sclerosis and other demyelinating diseases, including neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody disease (MOGAD). Dr. McDonald also provides comprehensive care to general neurology patients.

    Dr. McDonald completed her internship and adult neurology residency at the University of Utah. She has a long-standing interest in multiple sclerosis care and went on to complete a two-year clinical MS/neuroimmunology fellowship at Stanford Health Care Multiple Sclerosis Center. Dr. McDonald received the National MS Society’s Sylvia Lawry Physician Fellowship, including formalized training in conducting clinical trials. As part of her fellowship, she completed a master’s degree in epidemiology and clinical research.